EP1102578A4 - Nouvel agent analgesique, anti-inflammatoire et cicatrisant - Google Patents

Nouvel agent analgesique, anti-inflammatoire et cicatrisant

Info

Publication number
EP1102578A4
EP1102578A4 EP99942002A EP99942002A EP1102578A4 EP 1102578 A4 EP1102578 A4 EP 1102578A4 EP 99942002 A EP99942002 A EP 99942002A EP 99942002 A EP99942002 A EP 99942002A EP 1102578 A4 EP1102578 A4 EP 1102578A4
Authority
EP
European Patent Office
Prior art keywords
inflammatory
wound healing
healing agent
new analgesic
analgesic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99942002A
Other languages
German (de)
English (en)
Other versions
EP1102578A1 (fr
Inventor
Jonathan W Nyce
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epigenesis Pharmaceuticals Inc
Original Assignee
Epigenesis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epigenesis Pharmaceuticals Inc filed Critical Epigenesis Pharmaceuticals Inc
Publication of EP1102578A1 publication Critical patent/EP1102578A1/fr
Publication of EP1102578A4 publication Critical patent/EP1102578A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP99942002A 1998-08-03 1999-08-03 Nouvel agent analgesique, anti-inflammatoire et cicatrisant Withdrawn EP1102578A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9509098P 1998-08-03 1998-08-03
US95090P 1998-08-03
PCT/US1999/017642 WO2000007566A1 (fr) 1998-08-03 1999-08-03 Nouvel agent analgesique, anti-inflammatoire et cicatrisant

Publications (2)

Publication Number Publication Date
EP1102578A1 EP1102578A1 (fr) 2001-05-30
EP1102578A4 true EP1102578A4 (fr) 2005-05-18

Family

ID=22249490

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99942002A Withdrawn EP1102578A4 (fr) 1998-08-03 1999-08-03 Nouvel agent analgesique, anti-inflammatoire et cicatrisant

Country Status (6)

Country Link
EP (1) EP1102578A4 (fr)
CN (1) CN1311665A (fr)
AU (1) AU5547099A (fr)
CA (1) CA2348637A1 (fr)
MX (1) MXPA01000973A (fr)
WO (1) WO2000007566A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1354640A (zh) * 1999-01-05 2002-06-19 东卡罗来纳大学 组合物和制剂及其在损伤感受剂,抗焦虑剂和合成代谢剂中的应用
CA2570245A1 (fr) * 2004-07-02 2006-01-12 Warner-Lambert Company Llc Compositions et methodes de traitement d'infections pathologiques
HU227970B1 (en) 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
CN101417121B (zh) * 2007-10-27 2011-09-28 董昌金 一种治疗皮肤烧烫冻伤的药物
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
EP2915882B1 (fr) * 2012-11-05 2018-10-17 Shionogi & Co., Ltd. Méthode d'évaluation de l'activité médicamenteuse d'un médicament ayant un effet thérapeutique ou préventif sur une maladie à laquelle est associée l'activité de l'el, et méthode de criblage à la recherche d'une substance inhibitrice de l'activité de l'el

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0382019A1 (fr) * 1989-01-31 1990-08-16 BIORESEARCH S.p.A. Utilisation des acides 5-méthyltétrahydrofolique et 5-formyltétrahydrofolique ainsi que de leurs sels pharmaceutiquement acceptables pour la préparation de compositions pharmaceutiques à libération contrôlée aptes à l'utilisation dans la thérapie des troubles dépressifs, et des compositions pharmaceutiques ainsi préparées
US5118505A (en) * 1988-01-28 1992-06-02 Koeltringer Peter Combination preparation for the treatment of nerve cell and nerve fibre diseases and injury
WO1998019690A1 (fr) * 1996-11-06 1998-05-14 Bristol-Myers Squibb Company Methode de traitement de la maladie d'alzheimer
EP0898965A2 (fr) * 1997-06-13 1999-03-03 EPROVA Aktiengesellschaft Utilisation de tetrahydrofolates pour moduler le taux de homocysteine
WO2000040172A1 (fr) * 1999-01-05 2000-07-13 East Carolina University Composition et formulations et leur utilisation comme nociceptifs, anti-anxiolytiques et anabolisants

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4225710A (en) * 1977-07-08 1980-09-30 Burroughs Wellcome Co. Pyrimido(4,5-c)pyridazines
CH673459A5 (fr) * 1987-05-15 1990-03-15 Eprova Ag
US5534513A (en) * 1991-09-05 1996-07-09 Taiho Pharmaceutical Company, Ltd. Antitumor potentiator and antitumor composition
US5438075A (en) * 1993-03-30 1995-08-01 Skubitz; Keith M. Oral glutamine to reduce stomatitis
US5660835A (en) * 1995-02-24 1997-08-26 East Carolina University Method of treating adenosine depletion
DE69728379T2 (de) * 1996-01-31 2005-02-24 South Alabama Medical Science Foundation, Mobile Lebensmittel und vitamin herstellungen mit natürlichem isomeren von reduzierten folaten

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118505A (en) * 1988-01-28 1992-06-02 Koeltringer Peter Combination preparation for the treatment of nerve cell and nerve fibre diseases and injury
EP0382019A1 (fr) * 1989-01-31 1990-08-16 BIORESEARCH S.p.A. Utilisation des acides 5-méthyltétrahydrofolique et 5-formyltétrahydrofolique ainsi que de leurs sels pharmaceutiquement acceptables pour la préparation de compositions pharmaceutiques à libération contrôlée aptes à l'utilisation dans la thérapie des troubles dépressifs, et des compositions pharmaceutiques ainsi préparées
WO1998019690A1 (fr) * 1996-11-06 1998-05-14 Bristol-Myers Squibb Company Methode de traitement de la maladie d'alzheimer
EP0898965A2 (fr) * 1997-06-13 1999-03-03 EPROVA Aktiengesellschaft Utilisation de tetrahydrofolates pour moduler le taux de homocysteine
WO2000040172A1 (fr) * 1999-01-05 2000-07-13 East Carolina University Composition et formulations et leur utilisation comme nociceptifs, anti-anxiolytiques et anabolisants

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CASTRO ALONSO F J ET AL: "Treatment of ocular toxoplasmosis", FARMACIA CLINICA, vol. 15, no. 2, March 1998 (1998-03-01), pages 119 - 124, XP009045489, ISSN: 0212-6583 *
DAVIES ET AL: "FACILITATORY AND DIRECT EXCITATORY EFFECTS OF FOLATE AND FOLINATE ON SINGLE NEURONES OF CAT CEREBRAL CORTEX", BIOCHEMICAL PHARMACOLOGY, PERGAMON, OXFORD, GB, vol. 13, no. 22, 1 July 1973 (1973-07-01), pages 1667 - 1668, XP001078712, ISSN: 0006-2952 *
KELLY G S: "Folates: supplemental forms and therapeutic applications.", ALTERNATIVE MEDICINE REVIEW : A JOURNAL OF CLINICAL THERAPEUTIC. JUN 1998, vol. 3, no. 3, June 1998 (1998-06-01), pages 208 - 220, XP009045488, ISSN: 1089-5159 *
KEPKA L ET AL: "Successful rescue in a patient with high dose methotrexate-induced nephrotoxicity and acute renal failure.", LEUKEMIA & LYMPHOMA. MAR 1998, vol. 29, no. 1-2, March 1998 (1998-03-01), pages 205 - 209, XP009045482, ISSN: 1042-8194 *
See also references of WO0007566A1 *

Also Published As

Publication number Publication date
WO2000007566A1 (fr) 2000-02-17
CA2348637A1 (fr) 2000-02-17
EP1102578A1 (fr) 2001-05-30
CN1311665A (zh) 2001-09-05
AU5547099A (en) 2000-02-28
MXPA01000973A (es) 2002-06-04

Similar Documents

Publication Publication Date Title
AU2000274774A1 (en) Wound site management and wound closure device
AU6367399A (en) Pyrrolidine compounds and medicinal utilization thereof
TWI316062B (en) Anti-inflammatory compounds and uses thereof
EP1073401A4 (fr) Formulation anesthesique topique
IL121652A0 (en) Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent
HK1040939A1 (en) A compound for tissue repair and the application thereof
AU7859800A (en) Topical nasal treatment
SI1014993T1 (en) New use for budesonide and formoterol
GB9929571D0 (en) Shaped wound dressings
AU758325C (en) Imidazole compounds and medicinal use thereof
AU5929499A (en) A wound treatment composition and a wound dressing containing it
EP1102578A4 (fr) Nouvel agent analgesique, anti-inflammatoire et cicatrisant
AU5615999A (en) A medical active water, manufacture and use thereof
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
EP1051267A4 (fr) Machine a cintrer par roulement-compression et dispositifs de formage allonges, et leur procedes de fabrication
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
GB9608145D0 (en) Wound healing
AU7559200A (en) Hypertriglyceridemia remedies and antiobestics
GB2347087B (en) Tape and tape dispenser
AU3035497A (en) Device for reducing the length, and optionally the width, of a cot
AU2001239631A1 (en) A new oligomer compound and a use thereof
AU1028000A (en) Medicament utilization and combination
GB9814555D0 (en) Wound healing
AU2001267827A1 (en) Anti-inflammatory and analgesic agents
AU3852800A (en) A construction and use thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010131

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: EPIGENESIS PHARMACEUTICALS, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20050406

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 29/00 B

Ipc: 7A 61P 25/00 B

Ipc: 7A 61P 23/00 B

Ipc: 7A 61P 13/12 B

Ipc: 7A 61P 9/00 B

Ipc: 7A 61P 3/00 B

Ipc: 7A 61K 45/06 B

Ipc: 7A 61K 31/519 A

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050301